ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AEYE vs DH // NET PROFIT MARGIN

AudioEye Inc. (NASDAQ) VS. Definitive Healthcare Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: AEYE 8 — DH 2
▲ NET PROFIT MARGIN LEADER: AEYE
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AEYE VS. DH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AEYE DH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 78.30% 75.90% +2.40 AEYE /gross-margins <GO>
Return on Invested Capital (ROIC) -12.10% -35.00% +22.90 AEYE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 2.62% 22.82% -20.20 DH /fcf-yield <GO>
Operating Margin -4.50% -60.00% +55.50 AEYE /operating-margins <GO>
Net Profit Margin ACTIVE -7.60% -57.50% +49.90 AEYE /net-margins <GO>
Revenue Growth (YoY) 14.50% -4.20% +18.70 AEYE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.42 0.20 +0.22 AEYE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 DH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 74.5 63.9 +10.58 AEYE /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $179.1M $162.4M $16.7M AEYE /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AEYE REV DH REV AEYE GROSS % DH GROSS % AEYE FCF DH FCF
FY 2025 $40.3M $241.5M 78.3% 75.9% $4.7M $37.1M
FY 2024 $35.2M $252.2M 79.4% 78.3% $2.6M $45.9M
FY 2023 $31.3M $251.4M — — $318.0K $41.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AEYE // BETA —
DH // BETA —